chr1-36098176-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_005202.4(COL8A2):​c.1505C>T​(p.Thr502Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00979 in 1,520,000 control chromosomes in the GnomAD database, including 1,061 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.016 ( 158 hom., cov: 33)
Exomes 𝑓: 0.0091 ( 903 hom. )

Consequence

COL8A2
NM_005202.4 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 1.66

Publications

18 publications found
Variant links:
Genes affected
COL8A2 (HGNC:2216): (collagen type VIII alpha 2 chain) This gene encodes the alpha 2 chain of type VIII collagen. This protein is a major component of the basement membrane of the corneal endothelium and forms homo- or heterotrimers with alpha 1 (VIII) type collagens. Defects in this gene are associated with Fuchs endothelial corneal dystrophy and posterior polymorphous corneal dystrophy type 2. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2014]
COL8A2 Gene-Disease associations (from GenCC):
  • corneal dystrophy, Fuchs endothelial, 1
    Inheritance: AD Classification: STRONG Submitted by: G2P
  • posterior polymorphous corneal dystrophy 2
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • Fuchs' endothelial dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • posterior polymorphous corneal dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0017183721).
BP6
Variant 1-36098176-G-A is Benign according to our data. Variant chr1-36098176-G-A is described in ClinVar as Benign. ClinVar VariationId is 1287683.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.221 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL8A2NM_005202.4 linkc.1505C>T p.Thr502Met missense_variant Exon 4 of 4 ENST00000397799.2 NP_005193.1 P25067
COL8A2NM_001294347.2 linkc.1310C>T p.Thr437Met missense_variant Exon 4 of 4 NP_001281276.1 P25067E9PP49

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL8A2ENST00000397799.2 linkc.1505C>T p.Thr502Met missense_variant Exon 4 of 4 5 NM_005202.4 ENSP00000380901.1 P25067
COL8A2ENST00000481785.1 linkc.1310C>T p.Thr437Met missense_variant Exon 2 of 2 1 ENSP00000436433.1 E9PP49
COL8A2ENST00000303143.9 linkc.1505C>T p.Thr502Met missense_variant Exon 2 of 2 2 ENSP00000305913.4 P25067

Frequencies

GnomAD3 genomes
AF:
0.0160
AC:
2434
AN:
151690
Hom.:
158
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00827
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0273
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.232
Gnomad SAS
AF:
0.0114
Gnomad FIN
AF:
0.0267
Gnomad MID
AF:
0.00318
Gnomad NFE
AF:
0.00179
Gnomad OTH
AF:
0.0144
GnomAD2 exomes
AF:
0.0299
AC:
3798
AN:
127074
AF XY:
0.0270
show subpopulations
Gnomad AFR exome
AF:
0.00680
Gnomad AMR exome
AF:
0.0387
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.239
Gnomad FIN exome
AF:
0.0285
Gnomad NFE exome
AF:
0.00149
Gnomad OTH exome
AF:
0.0208
GnomAD4 exome
AF:
0.00910
AC:
12444
AN:
1368192
Hom.:
903
Cov.:
37
AF XY:
0.00892
AC XY:
6001
AN XY:
672584
show subpopulations
African (AFR)
AF:
0.00738
AC:
226
AN:
30630
American (AMR)
AF:
0.0397
AC:
1304
AN:
32818
Ashkenazi Jewish (ASJ)
AF:
0.000289
AC:
7
AN:
24248
East Asian (EAS)
AF:
0.202
AC:
7132
AN:
35352
South Asian (SAS)
AF:
0.00790
AC:
619
AN:
78354
European-Finnish (FIN)
AF:
0.0254
AC:
997
AN:
39274
Middle Eastern (MID)
AF:
0.00550
AC:
22
AN:
4002
European-Non Finnish (NFE)
AF:
0.000956
AC:
1020
AN:
1066992
Other (OTH)
AF:
0.0198
AC:
1117
AN:
56522
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
683
1367
2050
2734
3417
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
166
332
498
664
830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0161
AC:
2438
AN:
151808
Hom.:
158
Cov.:
33
AF XY:
0.0181
AC XY:
1345
AN XY:
74200
show subpopulations
African (AFR)
AF:
0.00825
AC:
342
AN:
41452
American (AMR)
AF:
0.0279
AC:
426
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3468
East Asian (EAS)
AF:
0.232
AC:
1179
AN:
5086
South Asian (SAS)
AF:
0.0114
AC:
55
AN:
4824
European-Finnish (FIN)
AF:
0.0267
AC:
283
AN:
10600
Middle Eastern (MID)
AF:
0.00342
AC:
1
AN:
292
European-Non Finnish (NFE)
AF:
0.00179
AC:
121
AN:
67776
Other (OTH)
AF:
0.0142
AC:
30
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
106
212
318
424
530
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
34
68
102
136
170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00502
Hom.:
4
Bravo
AF:
0.0176
TwinsUK
AF:
0.00108
AC:
4
ALSPAC
AF:
0.00104
AC:
4
ExAC
AF:
0.0123
AC:
1168
Asia WGS
AF:
0.0990
AC:
343
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Jan 07, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 25, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

COL8A2-related disorder Benign:1
Sep 10, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.060
BayesDel_addAF
Benign
-0.52
T
BayesDel_noAF
Benign
-0.37
CADD
Benign
16
DANN
Benign
0.94
DEOGEN2
Benign
0.11
T;T;.
Eigen
Benign
-0.57
Eigen_PC
Benign
-0.50
FATHMM_MKL
Benign
0.029
N
LIST_S2
Benign
0.53
.;T;T
MetaRNN
Benign
0.0017
T;T;T
MetaSVM
Benign
-0.97
T
MutationAssessor
Benign
0.065
N;N;.
PhyloP100
1.7
PrimateAI
Benign
0.35
T
PROVEAN
Benign
-0.47
N;N;N
REVEL
Benign
0.14
Sift
Benign
0.27
T;T;T
Sift4G
Benign
0.22
T;T;T
Polyphen
0.0010
B;B;.
Vest4
0.035
MPC
0.31
ClinPred
0.0059
T
GERP RS
3.0
Varity_R
0.020
gMVP
0.16
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs117860804; hg19: chr1-36563777; API